BAM
MNTA

Blueshift Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Blueshift Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,420
Closed -$389K – 955
2020
Q3 		$389K Buy
+7,420
New +$307K 0.05% 396

Blueshift Asset Management's MNTA Position: Q4 2020 in Review

Blueshift Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 7,420 shares — an estimated $389K sold.

Blueshift Asset Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $389K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Blueshift Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Blueshift Asset Management sold 7,420 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $389K.
  • Blueshift Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Blueshift Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $389K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Blueshift Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.